Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Jazz Pharmaceuticals in the Drug Discovery & Development Pharma 50

Jazz Pharmaceuticals

Rank: 50

2021 Rank: 49

Dublin, Ireland
www.jazzpharma.com

2021 Revenues ($USD) : $3,094,238,000
2021 R&D spend : $505,748,000
2021 Number of Employees : 3,200
Fiscal Year End : 12/31/2021
Leader : CEO Bruce Cozadd

Jazz Pharmaceuticals

[Jazz Pharmaceuticals corporate headquarters in Dublin, Ireland. Image courtesy of Jazz Pharmaceuticals]

Jazz Pharmaceuticals specializes in developing therapies in neurosciences, hematology and oncology. Its best-selling drug is Xyrem for treating cataplexy and excessive daytime sleepiness in adult and pediatric patients with narcolepsy. Other bestsellers include Epidiolex/Epidyolex (cannabidiol) to treat seizures associated with two forms of epilepsy, and Zepzelca, a treatment for metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy. In May 2021, the Dublin, Ireland–based company completed its $7.2 billion acquisition of GW Pharmaceuticals. —BB

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50